CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 89 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q3 2021. The put-call ratio across all filers is 0.71 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,856 | -99.9% | 16,800 | -44.9% | 0.00% | – |
| Q3 2022 | $3,003,000 | +74975.0% | 30,500 | +100.0% | 0.00% | – |
| Q2 2022 | $4,000 | -50.0% | 15,250 | -3.2% | 0.00% | – |
| Q1 2022 | $8,000 | -33.3% | 15,750 | -18.2% | 0.00% | – |
| Q4 2021 | $12,000 | -50.0% | 19,250 | -18.4% | 0.00% | – |
| Q3 2021 | $24,000 | -40.0% | 23,590 | +9.3% | 0.00% | – |
| Q2 2021 | $40,000 | -13.0% | 21,590 | -8.4% | 0.00% | -100.0% |
| Q1 2021 | $46,000 | +27.8% | 23,570 | -15.0% | 0.00% | – |
| Q4 2020 | $36,000 | -99.9% | 27,740 | -19.3% | 0.00% | -100.0% |
| Q3 2020 | $62,000,000 | – | 34,370 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 5,045,870 | $3,107,000 | 1.71% |
| ETF MANAGERS GROUP, LLC | 14,138,998 | $8,534,000 | 0.17% |
| Ikarian Capital, LLC | 948,526 | $584,000 | 0.09% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 318,668 | $196,000 | 0.03% |
| Platform Technology Partners | 45,000 | $28,000 | 0.01% |
| XTX Topco Ltd | 34,476 | $21,000 | 0.01% |
| PINNACLE ASSOCIATES LTD | 947,083 | $583,000 | 0.01% |
| Penserra Capital Management LLC | 537,236 | $330,000 | 0.01% |
| Mirae Asset Global Investments Co., Ltd. | 4,070,006 | $2,506,000 | 0.01% |
| Tekla Capital Management LLC | 154,310 | $95,000 | 0.00% |